TY - JOUR
T1 - Screening of Anorectal and Oropharyngeal Samples Fails to Detect Bacteriophages Infecting Neisseria gonorrhoeae
AU - Laumen, Jolein Gyonne Elise
AU - Abdellati, Saïd
AU - Manoharan-Basil, Sheeba Santhini
AU - Van Dijck, Christophe
AU - Van den Bossche, Dorien
AU - De Baetselier, Irith
AU - de Block, Tessa
AU - Malhotra-Kumar, Surbhi
AU - Soentjes, Patrick
AU - Pirnay, Jean Paul
AU - Kenyon, Chris
AU - Merabishvili, Maia
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2
Y1 - 2022/2
N2 - There are real concerns that Neisseria gonorrhoeae may become untreatable in the near future due to the rapid emergence of antimicrobial resistance. Alternative therapies are thus urgently required. Bacteriophages active against N. gonorrhoeae could play an important role as an antibioticsparing therapy. To the best of our knowledge, no bacteriophages active against N. gonorrhoeae have ever been found. The aim of this study was to screen for bacteriophages able to lyse N. gonorrhoeae in oropharyngeal and anorectal swabs of 74 men who have sex with men attending a sexual health clinic in Antwerp, Belgium. We screened 210 swabs but were unable to identify an anti-gonococcal bacteriophage. This is the first report of a pilot screening that systematically searched for anti-gonococcal phages directly from clinical swabs. Further studies may consider screening for phages at other anatomical sites (e.g., stool samples, urine) or in environmental settings (e.g., toilet sewage water of sex clubs or sexually transmitted infection clinics) where N. gonorrhoeae can be found.
AB - There are real concerns that Neisseria gonorrhoeae may become untreatable in the near future due to the rapid emergence of antimicrobial resistance. Alternative therapies are thus urgently required. Bacteriophages active against N. gonorrhoeae could play an important role as an antibioticsparing therapy. To the best of our knowledge, no bacteriophages active against N. gonorrhoeae have ever been found. The aim of this study was to screen for bacteriophages able to lyse N. gonorrhoeae in oropharyngeal and anorectal swabs of 74 men who have sex with men attending a sexual health clinic in Antwerp, Belgium. We screened 210 swabs but were unable to identify an anti-gonococcal bacteriophage. This is the first report of a pilot screening that systematically searched for anti-gonococcal phages directly from clinical swabs. Further studies may consider screening for phages at other anatomical sites (e.g., stool samples, urine) or in environmental settings (e.g., toilet sewage water of sex clubs or sexually transmitted infection clinics) where N. gonorrhoeae can be found.
KW - Antimicrobial resistance
KW - Bacteriophage screening
KW - Human anorectal swabs
KW - Human oropharyngeal swabs
KW - Neisseria gonorrhoeae
KW - Phage therapy
UR - http://www.scopus.com/inward/record.url?scp=85125102525&partnerID=8YFLogxK
U2 - 10.3390/antibiotics11020268
DO - 10.3390/antibiotics11020268
M3 - Article
AN - SCOPUS:85125102525
SN - 2079-6382
VL - 11
JO - Antibiotics
JF - Antibiotics
IS - 2
M1 - 268
ER -